Detalhe da pesquisa
1.
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
Hematol Oncol
; 41(4): 743-752, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37086447
2.
Combination of a mitogen-activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion-based residual disease and prevents re-expansion of FLT3-ITD acute myeloid leukaemia.
Br J Haematol
; 191(2): 231-242, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32394450
3.
Tyrosine kinase inhibitor insensitivity of non-cycling CD34+ human acute myeloid leukaemia cells with FMS-like tyrosine kinase 3 mutations.
Br J Haematol
; 154(4): 457-65, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21689085
4.
The role of second autografts in the management of myeloma at first relapse.
Haematologica
; 91(1): 141-2, 2006 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-16434386
5.
The combination of cyclophosphomide, thalidomide and dexamethasone is an effective alternative to cyclophosphamide - vincristine - doxorubicin - methylprednisolone as induction chemotherapy prior to autologous transplantation for multiple myeloma: a case-matched analysis.
Leuk Lymphoma
; 47(11): 2335-8, 2006 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17107906
6.
Benzene and the hemopoietic stem cell.
Chem Biol Interact
; 153-154: 217-22, 2005 May 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-15935819
7.
Isolated bone marrow involvement in diffuse large B cell lymphoma: a report of three cases with review of morphological, immunophenotypic and cytogenetic findings.
Leuk Lymphoma
; 45(4): 769-75, 2004 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-15160954
8.
Long-term outcomes of previously untreated myeloma patients: responses to induction chemotherapy and high-dose melphalan incorporated within a risk stratification model can help to direct the use of novel treatments.
Br J Haematol
; 129(5): 607-14, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15916682